BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15159320)

  • 1. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.
    Pearson T; Caporaso JG; Yellowhair M; Bokulich NA; Padi M; Roe DJ; Wertheim BC; Linhart M; Martinez JA; Bilagody C; Hornstra H; Alberts DS; Lance P; Thompson PA
    Cancer Med; 2019 Feb; 8(2):617-628. PubMed ID: 30652422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
    Wertheim BC; Smith JW; Fang C; Alberts DS; Lance P; Thompson PA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):197-204. PubMed ID: 22058145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
    Narisawa T; Fukaura Y; Takeba N; Nakai K
    Jpn J Cancer Res; 2002 Feb; 93(2):143-50. PubMed ID: 11856477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.
    Yue PF; Zhang WJ; Yuan HL; Yang M; Zhu WF; Cai PL; Xiao XH
    AAPS PharmSciTech; 2008; 9(1):322-9. PubMed ID: 18446498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study.
    Lakić B; Škrbić R; Uletilović S; Mandić-Kovačević N; Grabež M; Šarić MP; Stojiljković MP; Soldatović I; Janjetović Z; Stokanović A; Stojaković N; Mikov M
    J Diabetes Res; 2024; 2024():4187796. PubMed ID: 38455850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of
    Dai S; Zhou S; Ju Y; Yao W; Tang Y; Zheng J; Ma S; Zhang Y; Zhang L
    Front Pharmacol; 2023; 14():1249910. PubMed ID: 38026948
    [No Abstract]   [Full Text] [Related]  

  • 9. Smooth muscle contractile responses to bile acids in mouse ileum require TGR5 but not ASBT.
    Chang DS; Soni KG; Preidis GA
    Front Neurol; 2024; 15():1334319. PubMed ID: 38721114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats.
    Milivojac T; Grabež M; Krivokuća A; Maličević U; Gajić Bojić M; Đukanović Đ; Uletilović S; Mandić-Kovačević N; Cvjetković T; Barudžija M; Vojinović N; Šmitran A; Amidžić L; Stojiljković MP; Čolić M; Mikov M; Škrbić R
    Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38578526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biocompatibility and the metabolic impact of thermoresponsive, bile acid-based nanogels on auditory and macrophage cell lines.
    Kovacevic B; Raj Wagle S; Mihaela Ionescu C; Foster T; Đanić M; Mikov M; Mooranian A; Al-Salami H
    Eur J Pharm Biopharm; 2023 Sep; 190():248-257. PubMed ID: 37562725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity as a determinant of fecal bile acid levels.
    Wertheim BC; Martínez ME; Ashbeck EL; Roe DJ; Jacobs ET; Alberts DS; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1591-8. PubMed ID: 19383885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic Synthesis of New Acetoacetate-Ursodeoxycholic Acid Hybrids as Potential Therapeutic Agents and Useful Synthetic Scaffolds as Well.
    Venturi V; Marchesi E; Perrone D; Costa V; Catani M; Aprile S; Lerin LA; Zappaterra F; Giovannini PP; Preti L
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans.
    Tuncer I; Harman M; Colak Y; Arslan I; Turkdogan MK
    Gastroenterol Res Pract; 2012; 2012():159438. PubMed ID: 22611378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis.
    Tajima K; Miuma S; Miyaaki H; Matsuo S; Shimakura A; Mori T; Takahashi K; Nakao Y; Fukushima M; Haraguchi M; Sasaki R; Ozawa E; Nakao K
    Hepatol Res; 2024 May; ():. PubMed ID: 38779914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids in treatment of ocular disease.
    Boatright JH; Nickerson JM; Moring AG; Pardue MT
    J Ocul Biol Dis Infor; 2009 Sep; 2(3):149-159. PubMed ID: 20046852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2.
    Marchesi E; Gentili V; Bortolotti D; Preti L; Marchetti P; Cristofori V; Fantinati A; Rizzo R; Trapella C; Perrone D; Navacchia ML
    ACS Omega; 2023 Nov; 8(47):45078-45087. PubMed ID: 38046338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Specific Bile Acid Profile of Shock: A Hypothesis Generating Appraisal of the Literature.
    Harnisch LO; Moerer O
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33256244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment.
    Setchell KD; Galzigna L; O'Connell N; Brunetti G; Tauschel HD
    Aliment Pharmacol Ther; 2005 Mar; 21(6):709-21. PubMed ID: 15771757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.
    Palma J; Reyes H; Ribalta J; Hernández I; Sandoval L; Almuna R; Liepins J; Lira F; Sedano M; Silva O; Tohá D; Silva JJ
    J Hepatol; 1997 Dec; 27(6):1022-8. PubMed ID: 9453428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.